Search by Drug Name or NDC

    NDC 69238-2027-02 Spironolactone 25 mg/5mL Details

    Spironolactone 25 mg/5mL

    Spironolactone is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals NY LLC. The primary component is SPIRONOLACTONE.

    Product Information

    NDC 69238-2027
    Product ID 69238-2027_e25b36dd-7948-4481-8994-13658f1f337f
    Associated GPIs
    GCN Sequence Number 046605
    GCN Sequence Number Description spironolactone ORAL SUSP 25 MG/5 ML ORAL
    HIC3 R1H
    HIC3 Description POTASSIUM SPARING DIURETICS
    GCN 15596
    HICL Sequence Number 002901
    HICL Sequence Number Description SPIRONOLACTONE
    Brand/Generic Generic
    Proprietary Name Spironolactone
    Proprietary Name Suffix n/a
    Non-Proprietary Name Spironolactone
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/5mL
    Substance Name SPIRONOLACTONE
    Labeler Name Amneal Pharmaceuticals NY LLC
    Pharmaceutical Class Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA215572
    Listing Certified Through 2024-12-31

    Package

    NDC 69238-2027-02 (69238202702)

    NDC Package Code 69238-2027-2
    Billing NDC 69238202702
    Package 473 mL in 1 BOTTLE (69238-2027-2)
    Marketing Start Date 2023-09-08
    NDC Exclude Flag N
    Pricing Information N/A